Aligos Therapeutics Inc Sustainability Reports
Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for viral and liver diseases. The company creates targeted drug candidates for chronic hepatitis B, metabolic dysfunction-associated steatohepatitis, and other high unmet medical needs.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300UU2UJIKJYX0S67
FIGI: BBG00QX7QH77
2 reports from 2021 to 2023
